Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma
Complete Title: Low Dose Mosunetuzumab For Indolent B-Cell Lymphoma
Trial Phase: II
Investigator: Ajay Gopal
This phase II trial tests the safety, side effects and effectiveness of mosunetuzumab in treating patients with slow growing (indolent) B-cell lymphoma. Mosunetuzumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread.
Keywords:
- Lymphoma, Follicular
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.